Back to search

MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION

Data up to Jan 2025

Published2000
Citations409
References28
Clinical Trials (1)

Total Citations Per Year

Abstract

References (28)

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

1996 • 1,019 citations

PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL COMBINED WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR PREVENTION OF ACUTE REJECTION

1995 • 985 citations

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection

1995 • 910 citations

SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION

1999 • 886 citations

Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

1998 • 875 citations

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

1997 • 757 citations

REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2

1999 • 483 citations

Rethinking Chronic Allograft Nephropathy

1999 • 443 citations

Chronic allograft nephropathy: An update

1999 • 367 citations

REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1

1999 • 307 citations

IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1

1998 • 293 citations

Chronic renal transplant loss

1995 • 254 citations

Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial

1999 • 198 citations

MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION: 3-YEAR RESULTS FROM THE PLACEBO-CONTROLLED TRIAL1

1999 • 185 citations

Mycophenolate mofetil attenuates renal injury in the rat remnant kidney

1998 • 181 citations

Suppression of the humoral immune response by mycophenolate mofetil

1998 • 177 citations

Tacrolimus (FK 506) in Kidney Transplantation: Three-Year Survival Results of the US Multicenter, Randomized, Comparative Trial

1998 • 156 citations

A NOVEL APPROACH TO THE TREATMENT OF CHRONIC ALLOGRAFT NEPHROPATHY1

1997 • 155 citations

Mycophenolate mofetil in cadaveric renal transplantation

1999 • 148 citations

Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease

1997 • 148 citations

Combining an Antiproteinuric Approach with Mycophenolate Mofetil Fully Suppresses Progressive Nephropathy of Experimental Animals

1999 • 140 citations

Clinical correlates to chronic renal allograft rejection.

1997 • 52 citations

From mice to man: the preclinical history of mycophenolate mofetil

1996 • 35 citations

FK 506 in kidney transplantation: Results of the U.S.A. randomized comparative phase III study

1997 • 33 citations

The FK506 in kidney transplant : Results of the U.S.A. Randomized Comparative Phase III study.

1997 • 22 citations

Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: Status of the MYC 1866 study at 1 year

1997 • 19 citations

Effect of Mycophenolate Mofetil on the In Vivo Infiltration of Lymphocytes in the Rat Remnant Kidney

1998 • 12 citations

Book Review Renal Transplantation By Ron Shapiro, Richard L. Simmons, and Thomas E. Starzl. Stamford, Conn., Appleton & Lange, 1997. 572 pp., illustrated. $100. 0-8385-8383-0

1998 • 2 citations

Cited By (0)

Loading...
MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION (2000) – Transplantation | Metascience Observatory Explorer